Seminars in Oncology
Volume 31, Issue 1 , Pages 90-119, February 2004

Apoptosis in cancer—implications for therapy☆

  • Henning Schulze-Bergkamen

      Affiliations

    • Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany
    • ,
  • Peter H Krammer

      Affiliations

    • Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany
    • Corresponding Author InformationAddress reprint requests to Peter H. Krammer, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by the Deutsche Forschungsgemeinschaft (DFG), Deutsche Krebshilfe/Dr Mildred Scheel-Stiftung, Tumorzentrum Heidelberg/Mannheim, the Medical Faculty of the University of Heidelberg, and the National Cancer Center, Bethesda, MD.

PII: S0093-7754(03)00568-2

doi:10.1053/j.seminoncol.2003.11.006

Seminars in Oncology
Volume 31, Issue 1 , Pages 90-119, February 2004

Article Tools

* Image Usage & Resolution